Skip to main content
PMC home page
Cell Discovery logoLink to Cell Discovery
. 2016 Mar 22;2:16006. doi: 10.1038/celldisc.2016.6

Taiman acts as a coactivator of Yorkie in the Hippo pathway to promote tissue growth and intestinal regeneration

Chao Wang 1, Meng-Xin Yin 1, Wei Wu 1, Liang Dong 1, Shimin Wang 1, Yi Lu 1, Jinjin Xu 1, Wenqing Wu 1, Sheng Li 2, Yun Zhao 1,3, Lei Zhang 1,3,*
PMCID: PMC4860958  PMID: 27462453

Abstract

The Hippo signaling pathway regulates tissue growth and organ size through controlling cell growth, proliferation and apoptosis. During these processes, the coactivator Yorkie partners with the transcription factor Scalloped to mediate Hippo pathway-regulated cellular functions. Here, we demonstrate that Taiman facilitates the activity of Yorkie. First, Taiman overexpression upregulates Hippo pathway-responsive genes and induces tissue overgrowth. Second, the loss of tai downregulates the expression of Hippo pathway target genes and reduces organ size as well as tissue overgrowth caused by Yorkie overexpression. Furthermore, we provide evidence that Taiman binds to Yorkie and facilitates the activity of Yorkie-Scalloped to activate the transcription of several Hippo pathway target genes. Moreover, we found that the C-terminus of Taiman is indispensable for the function of Taiman in Hippo signaling. Finally, we demonstrate that Taiman is also required in intestinal stem cell proliferation. Our findings suggest Taiman is an essential coactivator of Yorkie.

Keywords: Hippo pathway, proliferation, regeneration, Taiman, Yorkie

Introduction

Organ size control is a highly refined biological process, which is fundamental for multicellular life [1]. In this developmental process, cell growth, cell proliferation and cell apoptosis are delicately coordinated; yet the underlying mechanisms are not completely clarified. Previous studies have identified the Hippo pathway as a crucial mechanism controlling this process [2, 3]. Initially discovered in Drosophila, the Hippo signaling pathway has emerged as a central and highly conserved pathway that regulates tissue growth and organ size [1, 3]. Moreover, accumulating evidence has suggested that the Hippo pathway also has an important role in tissue homeostasis, tissue repair and even stem cell maintenance [4–7]. Especially, the Hippo pathway has an essential role in regulating Drosophila adult intestinal stem cell (ISC) proliferation [7, 8]. Malfunctions of Hippo signaling are closely related to a wide variety of human cancers and diseases [1].

A crucial aspect of research on Hippo signaling is the regulation of Yorkie (Yki) activity as the upstream signals converge on Yki eventually [6]. Yki and the transcription factor Scalloped (Sd) act together to regulate Hippo pathway target genes [9, 10]. Several recent studies have reported novel regulators of Yki, including Mask, Brahma and Ncoa6, which shed some light on Yki-mediated transcriptional regulation [11–14]. These cofactors interact with Yki and are necessary for Yki’s activity. However, our understanding of the regulation of Yki’s activity remains incomplete.

Taiman (Tai) was first reported as a coactivator of Ecdysone Receptor (EcR). Much of what we know about Tai comes from studies using Drosophila ovary. Tai cooperates with EcR to maintain the normal migration of the border cells [15]. AIB1, the mammalian homolog of Tai, is reported to be closely related to a wide range of human cancers, suggesting that it might have an important role in cell growth control [16–18]. Recently, Zhang et al. reported that Tai and Yki collaboratively induce germline genes in developing somatic epithelia to regulate tissue growth [19].

In the current study, we independently identify Tai as a coactivator of Yki through a genetic screening for new modulators of the Hippo pathway. We provide evidence that Tai overexpression upregulates Hippo pathway-responsive genes and induces tissue overgrowth. We show that the loss of Tai not only downregulates Hippo pathway target genes but also reduces organ size as well as tissue overgrowth caused by Yki overexpression. Furthermore, we provide evidence that Tai binds to Yki and facilitates the activity of Yki-Sd to activate the transcription of several Hippo pathway target genes. Moreover, C-terminus of Tai is found to be indispensable for the function of Tai in Hippo signaling. In addition, we demonstrate that Tai is also required in both dextran sulfate sodium (DSS)-induced and Yki-induced ISC proliferation.

Results

Identification of tai as a gene positively regulating tissue growth

To identify novel components of the Hippo pathway, we performed a genetic screen in which flies carrying GMR-Gal4 and UAS-Yki (referred to as GMR-Yki) were crossed with a collection of EP lines. The overgrown eye phenotype induced by overexpression of Yki provides a sensitive background for us to identify modulators of the Hippo pathway. Through screening the progeny of GMR-Yki and more than 10 000 EP lines, we found numerous enhancers and suppressors that can further enhance the eye overgrowth induced by Yki overexpression. We then analyzed the UAS element insertion sites of these lines for new candidates. In this screen, we found two EP lines ([X447], [D269]) that have the UAS element insertion in an intron of tai gene that could dramatically promote the overgrown phenotype of GMR-Yki (Figure 1a-d).

Figure 1.

Figure 1

Open in a new tab

Tai P-element insertion lines trigger tissue growth and enhance the Hippo pathway target gene expression. (a–c′) Side (a–c) and dorsal (a′–c′) views of adult fly eyes expressing UAS-Yki (a, a′), UAS-Yki+[X447] (b, b′) or UAS-Yki+[D269] (c, c′) with GMR-Gal4. Scale bars, 100 μm. (d) Schematic representation of the tai gene locus and P-element insertion sites. The splicing pattern of the major tai product is indicated, as are the sites of insertion of the P-element alleles. The predicted coding sequence is shaded. The insertion sites of [D269] and [X447] EP lines are in the third intron of tai gene. (e–j′) Control wing discs (e, e′) or wing discs expressing [D269] with hh-Gal4 (f, f′) were immunostained to show the expression of diap1-GFP (e–f′), Ex (g–h′) and bantam-GFP (BS) (i–j′). Arrows indicate the P-compartment. Scale bars, 50 μm.

To further determine whether the expression of tai EP line could affect the activity of Hippo pathway, [D269] was expressed under the control of hh-Gal4 driver that drives gene ectopically expressed in the posterior compartment (P-compartment) of wing imaginal discs. Then, the changes in expression levels of well-characterized Hippo pathway target genes (diap1, ex, bantam) were examined (Figure 1e-j′). As shown in Figure 1f-f′ and h-h′, the expression of [D269] led to the upregulation of diap1-GFP and ex. Meanwhile, the expression of a bantam sensor (BS), bantam-GFP, which inversely indicates the bantam microRNA level, was reduced by [D269] overexpression (Figure 1j-j′). Briefly, the overexpression of [D269] upregulated expression levels of the Hippo pathway target genes. The results presented above suggest that the expression of [D269] promotes tissue growth and influences Hippo signaling.

Tai overexpression induces tissue growth through Hippo signaling

To verify the functional relationship between tai and the Hippo pathway, we generated UAS-Tai transgenic flies. Consistent with the results in Figure 1, coexpression of Tai and Yki enhanced the eye overgrowth induced by Yki overexpression, though overexpression of Tai alone did not induce obvious overgrowth phenotype (Figure 2a-d′). In addition, the overexpression of Tai dramatically enhanced the increase of ectopic BrdU incorporation caused by GMR-Yki posterior to the second mitotic wave (Figure 2e-h), indicating a proliferation of boosted cells.

Figure 2.

Figure 2

Open in a new tab

Overexpression of Tai promotes tissue overgrowth induced by Yki and activates the expression of Hippo pathway target genes. (a–d′) Side (a–d) and dorsal (a′–d′) views of wild-type adult eye (a, a′), eyes expressing UAS-Tai (b, b′), UAS-Yki (c, c′) and UAS-Yki+UAS-Tai (d, d′) with GMR-Gal4. Scale bars, 100 μm. (e–h) BrdU incorporation in wild-type eye discs (e), eye discs expressing UAS-Tai (f), UAS-Yki (g), or UAS-Yki+UAS-Tai (h) with GMR-Gal4. Arrowheads indicate the position of second mitotic wave. Scale bars, 50 μm. (i–l′) Drosophila discs containing flip-out clones expressing UAS-Tai by act>CD2>Gal4 (AG4) were immunostained to show the expression of diap1-lacZ (i, i′), ex-lacZ (ex-Z) (j, j′) or bantam-GFP (BS) (k–l′). Clones expressing UAS-Tai were marked by the lack of CD2 staining and indicated by arrowheads. Scale bars, 50 μm.

We then expressed Tai in imaginal discs using Actin>CD2>Gal4 (referred as AG4) and examined the changes of expression levels of Hippo pathway target genes. As shown in Figure 2i-j′, overexpression of Tai induced a dramatic increase of diap1-lacZ (Figure 2i-i′) and ex-lacZ (ex-Z) (Figure 2j-j′) and obvious decrease of bantam-GFP (Figure 2k-l′), suggesting that the overexpression of Tai promotes the expression of Hippo pathway target genes. These findings confirm that overexpression of Tai induces cell proliferation and tissue overgrowth by activating the transcription of Hippo pathway target genes.

Loss of tai inhibits tissue growth by downregulation of Hippo pathway targets

To further assess the role of Tai in tissue growth and the regulation of Hippo target gene expression, we generated two RNAi transgenes targeting two different regions of tai (Supplementary Figure S1A). Both RNAi transgenes effectively knocked down endogenous Tai (Supplementary Figure S1B-C). Expression of UAS-Tai-RNAi by the eyeless-Gal4 (eyG4) driver, which drives gene to express in eye discs, resulted in a significant decrease of Drosophila eye size (Figure 3b compared with Figure 3a). In addition, expression of UAS-Tai-RNAi using the wing-disc-specific driver MS1096-Gal4 (MS1096) induced an obvious decrease in wing size (Figure 3c-e). These observations suggest that Tai is necessary for normal eye and wing development.

Figure 3.

Figure 3

Open in a new tab

Loss of Tai inhibits tissue growth and suppresses the expression of Hippo pathway target genes. (a, b) Side views of eyes from control adult fly (a) or fly expressing Tai-RNAi (TaiR) (b) under the control of eyeless-Gal4. Scale bars, 100 μm. (c, d) Dorsal view of wings from control adult fly (c) or fly expressing Tai-RNAi (d) with MS1096-Gal4. Scale bars, 250 μm. (e) The relative wing size comparing control wings (c) and wings expressing Tai-RNAi (d). The data were quantified using an unpaired t-test. The results represented the mean± s.e.m. ***P<0.001 (n>6) for each genotype. (f–g′′) Control wing discs (f–f′′) or wing discs expressing Tai-RNAi with hh-Gal4 (g–g′′) were immunostained to show the expression of Tai (f, g), DIAP1 (f′, g′) or bantam-GFP (f′′, g′′). The white dashed lines mark the boundary between anterior and posterior parts in wing discs. Arrows indicate the P-compartment. Scale bars, 50 μm. (h, i) Side views of adult eyes containing control clones (h) or taiD3 clones (i) induced by ey-Flp. Scale bars, 100 μm. (j, k) Dorsal views of adult wings containing control clones (j) or taiD3 clones (k) induced by MS1096-Flp. Scale bars, 250 μm. (l) The relative wing size comparing control wings (j) and wings containing taiD3 clones (k). The data were quantified using an unpaired t-test. The results represented the mean± s.e.m. **P<0.01 (n>6) for each genotype. (m–m′′) A large magnification view of eye discs carrying taiD3 mutant clones that immunostained to show the expression of DIAP1 (m, m′′). Clones are marked by GFP (m′) and indicated by the arrows. Scale bar, 25 μm. (n–n′′) Wing discs containing taiD3 mutant clones were immunostained to show the expression of bantam-GFP (n, n′′). Mutant cells are marked by the lack of lacZ expression (n′) and indicated by arrows. Scale bar, 25 μm.

We further tested whether the knockdown of Tai could result in downregulation of the expression of Hippo pathway target genes. As shown in Figure 3f′ and g′ and Supplementary Figure S1E′, Tai knockdown led to the decrease of diap1 ectopic expression and ex-lacZ. The expression of bantam microRNA was also suppressed by Tai knockdown that was indicated by an increase of bantam-GFP (compare Figure 3g′′ with f′′). These results suggest that Tai is crucial for normal tissue growth and the regulation of Hippo pathway target genes.

To further strengthen the conclusion from RNAi experiments, we generated tai mutant with CRISPR/Cas9 strategy (Supplementary Figure S1F-H). The deletion in taiD3 mutant leads to a stop codon in the N-terminus (Supplementary Figure S1F and G). In taiD3 homozygous clones generated using Mosaic Analysis with a Repressible Cell Marker system, endogenous Tai can hardly be detected (Supplementary Figure S1H). Meanwhile, the heterozygous progeny of taiD3 and another validated tai mutant tai 61G1 , taiD3/tai 61G1 , were lethal. These results suggest that taiD3 is a reliable mutant for further experiments.

We then determined whether tai mutant could suppress normal tissue growth. Using the eyeless-flipase (eyflp) and MS1096-flipase (MS1096flp), we generated taiD3 homozygous clones in Drosophila eyes and wings, respectively. As shown in Figure 3h-l, the loss of tai suppressed Drosophila tissue growth. Correspondingly, we checked whether the loss of tai leads to a downregulation of Hippo pathway target gene expression. Of note, in taiD3 mutant clones, Diap1 protein level was decreased (Figure 3m-m′′). In addition, bantam microRNA level, indicated by the upregulation of bantam-GFP, was reduced in taiD3 mutant clones (Figure 3n-n′′). All these findings further implicate that Tai regulates the expression of Hippo pathway-responsive genes and functions in growth control.

Tai acts downstream of the Hippo pathway

According to the observations demonstrated in previous sections, we next determined the functional relationship between Tai and the components of Hippo signaling pathway through genetic analysis. During our experiments, it is noted that coexpression of UAS-Tai-RNAi with UAS-Yki reduced the eye overgrowth induced by Yki overexpression (Figure 4a-d′), suggesting that tai may act downstream of the Hippo pathway. To verify our presumption, we investigated the changes of the expression of Hippo pathway target genes in imaginal discs. Expression of Yki by the hh-Gal4 driver resulted in a dramatic upregulation of DIAP1 protein and induced an overgrowth of P-compartment in wing discs (Figure 4e-e′). Depletion of Tai using RNAi suppressed the elevated DIAP1 expression and the overgrowth induced by Yki (Figure 4f and g). In addition, we found that tai61G1 heterozygote reduced the eye overgrowth induced by Yki overexpression and enhanced the scalloped wing phenotype caused by Sd1 (Supplementary Figure S2A-E). Furthermore, we utilized the Mosaic Analysis with a Repressible Cell Marker system to examine the genetic interaction between tai and the Hippo pathway. As shown in Figure 4h-h′, warts (wts) mutant clones led to significant tissue overgrowth and elevated DIAP1 expression. Tai knockdown suppressed the overgrowth and reduced DIAP1 expression in wts mutant clones (Figure 4i and j). These results further support the notion that tai functions downstream of wts in the Hippo pathway.

Figure 4.

Figure 4

Open in a new tab

Genetic interaction between tai and the Hippo pathway components. (a–d′) Side (a–d) and dorsal (a′–d′) views of control adult fly eyes or eyes expressing Tai-RNAi or UAS-Yki or UAS-Yki+Tai-RNAi under the control of GMR-Gal4. Scale bars, 100 μm. (e–f′) Wing discs expressing UAS-Yki (e, e′) or UAS-Yki+Tai-RNAi (f, f′) with hh-Gal4 were immunostained to show the expression of DIAP1. The P-compartment is indicated by Yki staining (e′, f′) and arrows. Scale bars, 50 μm. (g) The comparison of P/A area ratio between wing discs shown in e, f. The data were quantified using an unpaired t-test. The results represented the mean± s.e.m. ***P<0.001 (n>6) for each genotype. (h–i′) Wing discs containing Mosaic Analysis with a Repressible Cell Marker (MARCM) clones of wts mutant (h, h′) and wts mutant with Tai-RNAi (V15709) (i, i′) were stained for DIAP1. Clones are marked by GFP and indicated by arrows. Scale bars, 50 μm. (j) The comparison of the size of MARCM clones shown in h, i. The data were quantified using an unpaired t-test. The results represented the mean± s.e.m. ***P<0.001 (n>6) for each genotype.

Tai is essential for Yki’s activity and functions in parallel to Yki in Hippo signaling

Given that tai functions downstream of wts, we next investigated how loss of tai compromised the activity of Yki using genetic analysis. To eliminate the interference of the activity change of the Hippo pathway, we took advantage of Yki active variant YkiS168A, which is not refrained by upstream Hippo pathway signals. As shown in Figure 5a-b′, depletion of Tai by RNAi repressed the Drosophila eye overgrowth induced by YkiS168A overexpression. Tai knockdown also suppressed the overgrowth as well as the increased DIAP1 expression caused by YkiS168A in wing discs (Figure 5c-d′). Moreover, Tai RNAi rescued the decrease of bantam-GFP induced by Yki overexpression (Supplementary Figure S2F-H′). In addition, taiD3 limited the overgrowth in clones as well as the increased DIAP1 expression induced by excessive YkiS168A (Figure 5e-f′). The observations above suggest that Tai is necessary for Yki’s activity. It is also worth noting that, although depletion of Tai could inhibit tissue overgrowth induced by Yki overexpression, it could not block some elevated Hippo target genes, such as ex-lacZ (Supplementary Figure S2I-J′). It implies that Tai may not be the only coactivator required for the function of Yki.

Figure 5.

Figure 5

Open in a new tab

Tai is required for the activity of Yki and functions in parallel to Yki in the Hippo pathway. (a–b′) Side (a, b) and dorsal (a′, b′) views of eyes expressing YkiS168A (a, a′) or YkiS168A+Tai-RNAi with GMR-Gal4. Scale bars, 100 μm. (c–d′) Wing discs expressing YkiS168A (c, c′) or YkiS168A+Tai-RNAi (d, d′) under the control of hh-Gal4 were immunostained to show the expression of DIAP1. Ci marks the A-compartment and arrows indicate the P-compartment. (e–f′) Wing discs containing Mosaic Analysis with a Repressible Cell Marker clones of taiD3 mutant (e, e′) and taiD3 mutant with YkiS168A (f, f′) were stained for DIAP1. Clones are marked by GFP and indicated by the arrows. (g–i′) Wing discs expressing Tai (g, g′) or YkiRNAi (YkiR) (h, h′) or Tai+YkiRNAi (i, i′) under the control of hh-Gal4 were immunostained to show the expression of ex-lacZ. Ci marks the A-compartment and arrows indicate the P-compartment. Scale bars, 100 μm.

Furthermore, we examined whether Yki is dispensable for the function of Tai in Hippo signaling. As shown in Figure 5g-i′, expression of Tai induced a significant increase of ex-lacZ while coexpression of UAS-Yki-RNAi reduced ex-lacZ as well as wing disc size. These results indicate that Yki is indispensable for the function of Tai in the Hippo pathway. Taken together, Tai is essential for Yki’s activity and tai functions in parallel to yki in Hippo signaling.

Considering that Yki primarily binds to Sd to form transcription complex in Hippo signaling, we tested the functional relationship between sd and tai. Sd knockdown suppressed the elevated diap-GFP level caused by overexpression of Tai, suggesting that Sd is necessary for the function of Tai (Supplementary Figure S2K-M′). Interestingly, we found that the eye overgrowth induced by the expression of constitutively active Sd (SdGA) was not affected by Tai knockdown (Supplementary Figure S2N-O′). Consistently, Tai knockdown did not reduce the increase of diap1-lacZ expression induced by SdGA (Supplementary Figure S2P-Q′). These findings imply that tai functions upstream of sd and further strengthen that tai and yki work in parallel.

Tai interacts with Yki and facilitates the activity of Yki-Sd complex

Tai protein was first reported as a coactivator of EcR. It contains four major domains: a basic helix-loop-helix (bHLH), a PAS domain, LxxLL motifs and domain containing several polyglutamine stretches (PolyQ) (Figure 6a). To probe the molecular mechanism by which Tai functions in Hippo signaling, we performed several assays in S2 cells. In a dual luciferase assay, we used 3xSd2-Luc reporter to reflect the transcriptional activity of Sd-Yki. We found that expression of Tai significantly enhanced the luciferase reporter activity triggered by coexpression of Sd and Yki (Figure 6b). This finding suggests that Tai activates the Sd-Yki transcriptional complex in vitro. Furthermore, as we noted, a published work implicated that Tai is likely to be a binding partner of Yki [20]. A recent work showed that Tai binds to Yki through PPxY motifs and WW domains [19]. We verified the interaction between Tai and Yki by coimmunoprecipitation experiment. As shown in Figure 6c, Tai was coimmunoprecipitated with Yki. We also performed chromatin immunoprecipitation (ChIP)-PCR experiment and DNA pull-down experiment using S2 cells. Yki, Sd and Tai were cotransfected in S2 cells and then cells were collected for the following assays. Moreover, ChIP-PCR analysis showed that Tai binds to the promoter region of diap1 as the same as Sd does (Figure 6d and e). In addition, the biotin-tagged DNA fragment from the diap1 promoter pull-down Tai as well as Yki and Sd (Figure 6d and f). The results presented above supported the assumption that Tai interacts with Yki and facilitates the activity of Sd-Yki transcriptional complex.

Figure 6.

Figure 6

Open in a new tab

Tai binds to Yki and forms a complex with Sd-Yki on target gene promoter. (a) Schematic diagram of the Tai protein domain structure. (b) Tai acts synergistically with Sd-Yki to activate 3xSd2-luc reporter gene. S2 cells were transfected with indicated constructs and luciferase reporter gene, followed by dual luciferase assay. The data were quantified using an unpaired t-test. The results represented the mean± s.e.m. ***P<0.001 (n=3). (c) CoIP of Tai with HA-tagged Yki. S2 cells were transfected with the indicated Tai and Yki constructs, followed by immunoprecipitation and western blot analysis with the indicated antibodies. The specific bands were indicated by arrows. (d) Diagram of the diap1 promoter. Fragments for ChIP analysis and DNA pull-down are marked. Sd-binding motifs were indicated by arrowheads. th1 and th2 stand for the two regions containing several Sd-binding motifs. thB is the negative control. The biotin-tagged DNA fragment (7566-8148) also contains Sd-binding motif. (e) Tai binds to the promoter of diap1. Cells were transfected with HA-Sd, Flag-Yki and Myc-Tai, followed by ChIP assay with indicated antibodies. HA-Sd was added in as a positive control. (f) Tai, Sd and Yki bind to diap1 DNA sequences but not to actin. DNA pull-down with either actin or diap1 DNA sequences from extracts of S2 cells transfected with Myc-Tai, Flag-Yki and HA-Sd.

C-terminus of Tai is essential for the function of Tai in regulating Hippo signaling

We next mapped which domains of Tai mediate its function. Different truncations of Tai were generated and tested for their activities on promoting Sd-Yki transcriptional activity. Two Tai truncations were generated, namely TaiN (1-650aa) and TaiC (650aa-2036aa) (Figure 7a). In a dual luciferase assay, TaiN did not affect the transcriptional activity of Sd-Yki whereas TaiC significantly promoted the activity of Sd-Yki (Figure 7b). We also generated UAS-Myc-TaiN and UAS-Myc-TaiC transgenic flies. Consistent with the findings from experiments using S2 cells, coexpression with TaiN did not affect the eye overgrowth caused by GMR-Yki whereas coexpression of TaiC enhanced the GMR-Yki-induced phenotype (Supplementary Figure S2R-U). Of note, both in vitro and in vivo assays implicated that the function of TaiC is even stronger than that of Tai full length (Figure 7b and Supplementary Figure S2R-U). All these observations suggest that C-terminus of Tai is necessary and sufficient for the activity of Tai.

Figure 7.

Figure 7

Open in a new tab

Characterization of different domains of Tai. (a) Schematic diagram of the N- and C- truncations of Tai protein. (b) TaiC sufficiently enhances the activity of Sd-Yki to trigger 3xSd2-luc reporter gene whereas TaiN does not. S2 cells were transfected with indicated constructs and luciferase reporter gene, followed by dual luciferase assay. The data were quantified using an unpaired t-test. The results represented the mean± s.e.m. ***P<0.001, **P<0.01, n.s., no significant difference (n=3). Note that the activity of TaiC is even higher than that of Tai full length. (c) Schematic diagram of the different domains of Tai protein. (d) CoIP of Myc-tagged TaiP2, TaiP3, Tai-P5 and Flag-Yki. S2 cells were transfected with indicated constructs, followed by immunoprecipitation and western blot analysis with indicated antibodies. (e) Tai-P5 acts synergistically with Sd-Yki to activate 3xSd2-luc reporter gene. Tai acts synergistically with Sd-Yki to activate 3xSd2-luc reporter gene. S2 cells were transfected with indicated constructs and luciferase reporter gene, followed by dual luciferase assay. The data were quantified using an unpaired t-test. The results represented the mean± s.e.m. ***P<0.001, **P<0.01, *P<0.1, n.s., no significant difference (n=3). (f) Schematic diagram of the different variants of Tai protein C-terminus. (g) TaiC-ΔP3 enhances the transcriptional activity of Sd-Yki while TaiC-ΔP5 does not. The data were quantified using an unpaired t-test. The results represented the mean±s.e.m. ***P<0.001 (n=3), ***P<0.001, **P<0.01, *P<0.1, n.s., no significant difference (n=3).

To further clarify the essential domains of Tai, the full-length protein was cut into smaller truncated forms (P1–P5) (Figure 7c). As shown in Figure 7d, TaiP2, TaiP3 and Tai-P5 were co-immunoprecipitated with Yki. However, only Tai-P5 significantly enhanced the activity of Sd-Yki (Figure 7e), suggesting that Tai-P5 is crucial for the function of Tai. To further distinguish the roles of TaiP3 and Tai-P5, we generated TaiC-ΔP3 and TaiC-ΔP5 (Figure 7f) to dissect their function on promoting the activity of Sd-Yki. As shown in Figure 7g, TaiC-ΔP3 still maintained the ability to enhance Sd-Yki transcriptional activity, while TaiC-ΔP5 lost most of its function on promoting Sd-Yki activity, indicating that Tai-P5 is indispensable for the function of Tai in Hippo signaling. We further made Tai-ΔP5 to check its function. Tai-ΔP5 can bind to EcR but does not facilitate Yki-Sd transcription activity, suggesting that the EcR-binding ability is dispensable for Tai’s function in activating Yki-Sd (Supplementary Figure S2V and W). In conclusion, the results presented above suggested that C-terminus of Tai is essential for the function of Tai in the Hippo pathway and Tai-P5 has an indispensable role in this process.

Tai functions as a coactivator in both the Hippo pathway and the EcR pathway

Considering Tai is a multifunctional protein that was reported as a coactivator of EcR, it is an interesting question whether the function of Tai in the Hippo pathway is related to the EcR pathway. By genetic experiments, we found that, unlike depletion of Tai by RNAi, EcR RNAi neither changed the eye phenotype caused by Yki overexpression nor affected the expression of Hippo pathway target genes (Supplementary Figure S3A-D′). Meanwhile, we tested the function of the repressor of EcR signaling pathway, Abrupt (Ab), which antagonizes Tai to suppress EcR signaling. As shown in Supplementary Figure S3E-G′, the depletion of Ab by RNAi neither changed the eye phenotype caused by Yki overexpression nor affected the expression of Hippo pathway target genes. As EcR may be a default repressor in the absence of Tai, we also checked whether Tai depletion-induced phenotypes were caused by the loss of EcR. We took use of different EcR RNAi lines and found that expressing EcR RNAi transgenes could not rescue Tai RNAi-induced suppression of tissue growth (Supplementary Figure S3H-K). To further investigate the relationship between the Hippo pathway and the EcR pathway, we carried out in vivo staining assay and in vitro luciferase assay. The expression level of Broad Complex Z3 (BrC), a classic EcR target gene, was significantly increased upon Tai overexpression, while the increase of its protein level was not affected by Yki RNAi (Supplementary Figure S3L-N′). In a following luciferase assay using a EcR pathway reporter (pIND/lacZ(+5XEGRE), EcR-luc), coexpression with Yki slightly increased the activity of Tai in promoting EcR pathway activity (Supplementary Figure S3O). In another luciferase assay using Sd reporter, coexpression of EcR and Ultra-spiracle (Usp) slightly inhibited the function of Tai in promoting Sd-Yki activity, suggesting that Sd-Yki and EcR-Usp may contend with each other for the co-factor Tai (Supplementary Figure S3P). Thus, we conclude that Tai may act as a coactivator for both Hippo and EcR signaling.

Tai is required for ISC proliferation

Besides the roles of the Hippo pathway in growth control, it also has an essential role in regulating ISC proliferation. Thus, we investigated the function of Tai in ISC proliferation control. As shown in Figure 8a-b′′, the overexpression of Tai in ISCs/enteroblasts induced a significant increase of pH3-positive cell number, suggesting that Tai promotes ISC proliferation. Moreover, depletion of Yki by RNAi suppressed the upregulation of pH3-positive cell number induced by Tai overexpression, implying that this function of Tai depends on Yki (Figure 8c-e).

Figure 8.

Figure 8

Open in a new tab

Tai is required for ISC proliferation. (a–d′′) Midguts from adult flies of indicated genotypes were stained with pH3 antibody (red) and DAPI. esg-GFP marked the ISCs/enteroblasts (EBs) and pH3-positive cells were indicated with arrows. Scale bars, 50 μm. (e) The comparison of the number of pH3-positive cells shown in a–d′′. The data were quantified using an unpaired t-test. The results represented the mean+s.e.m. ***P<0.001, **P<0.01, *P<0.1, (n>5) for each genotype. (f–i′′) Midguts from adult flies of indicated genotypes treated with glucose or DSS were stained with pH3 antibody (red) and DAPI. esg-GFP marked the ISCs/EBs and pH3-positive cells were indicated with arrows. Scale bars, 50 μm. (j) The comparison of the number of pH3-positive cells shown in f–i′′. The data were quantified using an unpaired t-test. The results represented the mean+s.e.m. ***P<0.001, **P<0.01, *P<0.1, (n>5) for each genotype. Scale bars, 50 μm. (k–n′) Midguts from adult flies of indicated genotypes were stained with DAPI. esg-GFP marked the ISCs/EBs. Scale bars, 50 μm.

DSS-induced tissue damage stimulates ISC proliferation in a Hippo pathway-dependent manner. To determine whether Tai participates in the regulation of tissue damage-induced ISC proliferation, flies expressing Tai RNAi in ISCs/enteroblasts were treated with DSS. As shown in Figure 8f-j, Tai RNAi in ISCs/enteroblasts suppressed DSS-induced ISC proliferation, as indicated by the reduction in the number of esg-GFP positive and pH3-positive cells. These observations suggest that Tai is required for DSS-stimulated ISC proliferation. Furthermore, we tested whether Tai is required for Yki-induced ISC proliferation. Tai RNAi significantly reduced the esg-GFP-positive cell number induced by Yki overexpression, indicating that Tai RNAi inhibited Yki-induced ISC proliferation (Figure 8k-n′). All the results above suggest that Tai could sufficiently promote ISC proliferation and is required for both DSS-induced and Yki-induced ISC proliferation, which strengthen the assumption that Tai has an important role in the Hippo pathway. Moreover, EcR RNAi did not rescue the ISC over-proliferation induced by Tai, suggesting that Tai regulates ISC proliferation in a Yki-dependent manner rather than an EcR-dependent manner (Supplementary Figure S4A-E).

Discussion

The Hippo signaling pathway is a central and highly conserved pathway that controls tissue growth and organ size. Although many detailed regulation mechanisms of several core Hippo pathway components have been defined, the mechanism by which Sd-Yki activates target gene transcription is not completely understood. A study published recently by Zhang et al. [19] addressed that Tai and Yki collaboratively induce germline genes in developing somatic epithelia to regulate tissue growth. Here, we independently provide both genetic and biochemical evidence that Tai functions as a coactivator of Yki and facilitates the activity of Yki-Sd to activate the transcription of several Hippo pathway target genes. Moreover, we found that the C-terminus of Tai is essential for its function in the Hippo pathway. Furthermore, we demonstrated that Tai has an essential role in Drosophila ISC proliferation in a Yki-dependent manner.

Zhang et al. showed that Yki and Tai/EcR regulate canonical Hippo targets (diap1, ex and bantam) in parallel at endogenous Yki activity level [19]. In our hands, Tai was indispensable for Yki-induced upregulation of DIAP1 (Figure 5c-f′) and bantam microRNA (Supplementary Figure S2F-H′). Luciferase assay results indicated that Tai activated Yki-Sd complex, and EcR/Usp seems to contend for Tai with Yki-Sd complex (Supplementary Figure S3P). So, our findings demonstrated that Tai is indispensable for Yki's function in regulating some canonical Hippo targets transcription (such as diap1 and bantam) even at endogenous Yki activity level.

Another interesting finding of our study is that the C-terminus of Tai has an essential role in the function of Tai and Tai-P5 is indispensable. It should be mentioned that, although Tai-P5 enhanced the transcriptional activity of Sd-Yki in S2 cells, neither Tai-P5 nor TaiC-ΔP5 could promote tissue growth as TaiC did (data not shown). Maybe, the integrity of the C-terminus of Tai is prerequisite for its activity. The newly published work by Zhang et al. demonstrated that Tai binds to Yki through two PPxY motifs that are indispensable for the function of Tai [19]. In our mapping experiment, TaiP2 and TaiP3 are still able to bind to Yki (Figure 7d). Maybe these binding sites were masked in the full-length Tai.

It is also worth noting that overexpression of Tai was sufficient to induce the upregulation of Hippo pathway target genes and enhance the tissue overgrowth caused by Yki, which distinguishes Tai as a potential oncogene. The mammalian homolog of Tai, AIB1, is reported as an oncogene that tightly correlated with a wide variety of human cancers [21–23]. It will be interesting to examine the functional relationship between AIB1 and the Hippo pathway in mammalian cells. Moreover, in this study, we also noticed that TaiC had a stronger function than full-length Tai. Coincidentally, an N-terminal truncated AIB1, AIB1-Δ3, was reported as a more active form, which is overexpressed in breast cancer cells and in breast tumor tissue [24]. Therefore, subsequent research on Tai and the Hippo pathway may help us to clarify the underlying mechanisms and provide excellent targets for the development of new cancer therapeutics.

Materials and Methods

Plasmids and cloning

UAS-tai plasmid was a gift from Denise Montell lab. Truncations of Tai (TaiN, TaiC, Tai-P1, TaiP2, TaiP3, Tai-P4, Tai-P5, TaiC-ΔP3, TaiC-ΔP5) were constructed according to a standard protocol. For expression in S2 cells and flies, constructs were cloned into the pUAST-Myc vector. All primers used in this study can be requested. Other constructs used in this work are as follows: pUAST-Flag-Yki, pUAST-HA-SD, pIND/lacZ(+5XEGRE), pUAST-Flag-Hpo, pUAST-EcR.B and pUSAT-Usp.

Drosophila genetics

To make tai mutant fly stock, the CRISPR-Cas9 system was used to generate taiD3 allele following the previously described protocol. Tai RNAi fly stocks were generated according to the procedure described in the study by Wang et al. [25]. Fly stocks used in this study are as follows: UAS-Tai, UAS-Myc-TaiN, UAS-Myc-TaiC, tai61G1 (from Montell lab, University of California, Santa Barbara, CA, USA), taiD3, actin>CD2>Gal4, UAS-Tai-RNAi, Tai-RNAi (VDRC NO.15709, Vienna, Austria), UAS-Yki, UAS-Myc-YkiS168A, UAS-YkiRNAi, UAS-EcR.A-IR (Bloomington NO.9328, Bloomington, IN, USA), EcRRNAi (Bloomington NO.29374, NO. 50712, NO.58286), UAS-AbruptRNAi (Bloomington NO.29407, NO.32378), UAS-SdRNAi, wtslatsX1 , sd1 , hh-Gal4, GMR-Gal4, MS1096-Gal4, act>CD2>Gal4, eyless-Gal4, diap1-lacZ, diap3.5-GFP, ex-lacZ, bantam-GFP, eyflp; FRT40, hsflp;FRT40 M(2)24F arm-lacZ (from Jiang Lab, The University of Texas Southwestern Medical Center, TX, USA), hsflp actin-Gal4 UAS-GFP;FRT40 tubGal80, hsflp actin-Gal4 UAS-GFP; FRT82 tubGal80, esgGal4; tubGal80ts.

All genetic experiments were conducted at 25 °C unless otherwise indicated. FLP/FRT-mediated mitotic recombination was induced 3 days after eggs were laid. To this end, the larvae were incubated at 37 °C for 30 min to generate mutant clones. To induce conditional expression in adult flies, tub-Gal80ts flies were maintained at 18 °C though development, and then 2–6-day-old adult females were transferred to 29 °C for 7–9 days before dissection.

Cell culture, transfection, immunoprecipitation, western blot analysis, luciferase reporter assay and immunostaining

S2 cells were cultured in Drosophila Schneider’s Medium (Invitrogen, Carlsbad, CA, USA) with 10% heat-inactivated fetal bovine serum, 100 U ml−1 of penicillin, and 100 mg ml−1 of Streptomycin at 25 °C. Cell transfection was performed using LipofectAMINE (Invitrogen, cat. no. 11668-019) according to the manufacturer’s instructions. The cells were harvested 48 h after transfection. For the luciferase reporter assay, the 3xSd2-Luc reporter system has been carried out as described [26]. For the EcR luciferase reporter assay, S2 cells were transfected with pIND/lacZ(+5XEGRE) (the reporter), Renilla (the internal control) and other indicated plasmids. Twelve hours after transfection, cells were treated with dimethyl sulfoxide or 3 μM Muriateron A as indicated. Cells were harvested 24 h after treatment and assayed using the Dual Luciferase reporter assay system according to the manufacturer’s instructions (Promega, Madison, WI, USA, cat. no. E1960).

The luciferase assay was performed using the Dual Luciferase Assay System (Promega, cat. no. E1960). Immunostaining and confocal microscopy were performed according to standard protocols. BrdU assays were performed as described previously [9].

The following antibodies were used in this work: Rat anti-Tai (1:500; from Montell Lab), Rabbit anti-Tai (1:500; generated by Shanghai Immune Biotech CO., Ltd. (Shanghai, China) against TaiN and TaiC separately), mouse anti-Flag antibody (1:5 000; Sigma, St Louis, MO, USA, cat. no. M8823), mouse anti-Myc antibody (1:5 000; Santa Cruz, Santa Cruz, CA, USA, cat. no. sc-40), mouse anti-HA antibody (1:5 000; Sigma, cat. no. H3663), Rat anti-Cubitus interruptus (Ci) antibody (1:250; Developmental Studies Hybridoma Bank, DSHB, University of Iowa, Iowa City, IA, USA, cat. no. 2A1), rabbit anti-PH3 (1:200; Cell Signaling, Danvers, MA, USA, cat. no. 9701), mouse anti-BrC-Z3 (1:200; DSHB), Rabbit anti-lacZ antibody (1:500; Invitrogen, cat. no. A-11132), Rabbit anti-Ex (1:50), mouse anti-DIAP1 (1:50; a gift from Bruce A Hay, California Institute of Technology), mouse anti-BrdU (1:100; Abcam, Cambridge, UK, cat. no. ab6326).

Images of cells, imaginal discs and guts were acquired with a confocal microscope (LAS SP5; Leica, Wetzlar, Germany) using a ×20/1.25 NA oil objective (Leica) or ×40/1.4 NA oil objective (Leica) at room temperature. To reduce the variables in experiments involving comparison between different genotypes, all samples were stained, processed and imagined in parallel. Images were then processed, scaled and analyzed using Adobe Photoshop (Adobe, San Jose, CA, USA).

ChIP-PCR, DNA pull-down and real-time PCR

For ChIP, S2 cells were transfected with UAS-HA-Yki, UAS-Myc-Tai and UAS-HA-Sd. Forty-eight hours later, cells were cross-linked in 1% formaldehyde, and quenched in 125 mM glycine. Lysates were prepared in lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA pH 8.0, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS and protease inhibitors (Sigma, cat. no. P8340), followed by sonication prior to centrifugation. Indicated antibodies and Protein A/G agarose beads (Santa Cruz, cat. no. sc2003) were mixed with lysates and then washed (0.1% SDS, 1% Triton X-100, 2 mM EDTA pH 8, 150 mM NaCl, 20 mM Tris-HCl pH 8), eluted (50 mM NaHCO3, 1% SDS), extracted and suspended (in TE buffer). PCR primers are as follows: th1-F (5′-CAGTATACATACTTCTGC-3′), th1-R(5′-TTGATGGTAGGATGACAC-3′), th2-F (5′-GCTATTATATTATTGTG-3′), th2-R (5′-GGATTATGAGTGTGTGCG-3′), thB-F (5′-GATTTTATAATCTTATCG-3′), thB-R (5′-GCCTCCAGATTGTTTTAG-3′).

For DNA pull-down, S2 cells were transfected with UAS-HA-Yki, UAS-Myc-Tai and UAS-HA-Sd and then collected. The following procedure was performed as previously described [13].

For real-time PCR, RNA was isolated from wing discs. Coding DNA was synthesized with cDNA synthesis kit (Toyobo, cat. no. FSQ-301). RT-PCR was performed on ABI Fast 7500 using SYBR Green (Toyobo, Shanghai, China, cat. no. QPK-201). Rp49 was used as normalization control. Primers for real-time PCR are list as following: rp49-F(5′-CGGATCGATATGCTAAGCTGT-3′); rp49-R(5′-CGACGCACTCTGTTGTCG-3′); EcR-F (5′-AAGGAGAAGGACAAAATG-3′); EcR-R (5′-GTCATAAGGTCAAGAATCT-3′).

Statistical analysis

All statistical data were analyzed using Student's t-test by R 2.9.0 and expressed as mean±s.e.m. Results were considered statistically significant when P<0.05.

Acknowledgments

This work is supported by grants from the National Basic Research Program of China (973 Program 2012CB945001), the ‘Strategic Priority Research Program’ of the Chinese Academy of Sciences (XDA01010406), the National Natural Science Foundation of China (31171394, 31371462, 31501177), supported by the State Key Program of National Natural Science of China (31530043); the ‘Cross and cooperation in science and technology innovation team’ project of the Chinese Academy of Sciences, and the CAS/SAFEA International Partnership Program for Creative Research Teams. We would like to thank Denis Montell and Jin Jiang for supplying various reagents. We also thank the Bloomington and Vienna Stock Centers and DSHB and DGRC for fly stocks.

The authors declare no conflict of interest.

Footnotes

(Supplementary information is linked to the online version of the paper on the Cell Discovery website.)

Supplementary Figure S1
Click here for additional data file. (3.9MB, pdf)
Supplementary Figure S2
Click here for additional data file. (18.4MB, pdf)
Supplementary Figure S3
Click here for additional data file. (11.9MB, pdf)
Supplementary Figure S4
Click here for additional data file. (3.1MB, pdf)

References

  1. Pan D . The hippo signaling pathway in development and cancer. Dev Cell 2010; 19: 491–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Zhang L , Yue T , Jiang J . Hippo signaling pathway and organ size control. Fly 2009; 3: 68–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Halder G , Johnson RL . Hippo signaling: growth control and beyond. Development 2011; 138: 9–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Moroishi T , Hansen CG , Guan KL . The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 2015; 15: 73–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Zhao B , Tumaneng K , Guan KL . The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011; 13: 877–883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Yin M , Zhang L . Hippo signaling: A hub of growth control, tumor suppression and pluripotency maintenance. J Genet Genomics 2011; 38: 471–481. [DOI] [PubMed] [Google Scholar]
  7. Shaw RL , Kohlmaier A , Polesello C et al. The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 2010; 137: 4147–4158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ren F , Wang B , Yue T et al. Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci USA 2010; 107: 21064–21069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zhang L , Ren F , Zhang Q et al. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell 2008; 14: 377–387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wu S , Liu Y , Zheng Y , Dong J , Pan D . The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 2008; 14: 388–398. [DOI] [PubMed] [Google Scholar]
  11. Qing Y , Yin F , Wang W et al. The Hippo effector Yorkie activates transcription by interacting with a histone methyltransferase complex through Ncoa6. eLife 2014; 3: e02564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Oh H , Slattery M , Ma L et al. Yorkie promotes transcription by recruiting a histone methyltransferase complex. Cell Rep 2014; 8: 449–459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sidor CM , Brain R , Thompson BJ . Mask proteins are cofactors of Yorkie/YAP in the Hippo pathway. Curr Biol 2013; 23: 223–228. [DOI] [PubMed] [Google Scholar]
  14. Sansores-Garcia L , Atkins M , Moya IM et al. Mask is required for the activity of the Hippo pathway effector Yki/YAP. Curr Biol 2013; 23: 229–235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bai J , Uehara Y , Montell DJ . Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplified in breast cancer. Cell 2000; 103: 1047–1058. [DOI] [PubMed] [Google Scholar]
  16. Gojis O , Rudraraju B , Gudi M et al. The role of SRC-3 in human breast cancer. Nat Rev Clin Oncol 2010; 7: 83–89. [DOI] [PubMed] [Google Scholar]
  17. Song JM , Lu M , Liu FF , Du XJ , Xing BC . AIB1 as an independent prognostic marker in hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 2012; 16: 356–360. [DOI] [PubMed] [Google Scholar]
  18. List HJ , Reiter R , Singh B , Wellstein A , Riegel AT . Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res Treat 2001; 68: 21–28. [DOI] [PubMed] [Google Scholar]
  19. Zhang C , Robinson BS , Xu W et al. The ecdysone receptor coactivator Taiman links Yorkie to transcriptional control of germline stem cell factors in somatic tissue. Dev Cell 2015; 34: 168–180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kwon Y , Vinayagam A , Sun X et al. The Hippo signaling pathway interactome. Science 2013; 342: 737–740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Anzick SL , Kononen J , Walker RL et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997; 277: 965–968. [DOI] [PubMed] [Google Scholar]
  22. Sakakura C , Hagiwara A , Yasuoka R et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 2000; 89: 217–223. [PubMed] [Google Scholar]
  23. Iwase H , Omoto Y , Toyama T et al. Clinical significance of AIB1 expression in human breast cancer. Breast Cancer Res Treat 2003; 80: 339–345. [DOI] [PubMed] [Google Scholar]
  24. Reiter R , Oh AS , Wellstein A , Riegel AT . Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity. Oncogene 2004; 23: 403–409. [DOI] [PubMed] [Google Scholar]
  25. Wang H , Mu Y , Chen D . Effective gene silencing in Drosophila ovarian germline by artificial microRNAs. Cell Res 2011; 21: 700–703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wang C , Zhang W , Yin MX et al. Suppressor of Deltex mediates Pez degradation and modulates Drosophila midgut homeostasis. Nat Commun 2015; 6: 6607. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figure S1
Click here for additional data file. (3.9MB, pdf)
Supplementary Figure S2
Click here for additional data file. (18.4MB, pdf)
Supplementary Figure S3
Click here for additional data file. (11.9MB, pdf)
Supplementary Figure S4
Click here for additional data file. (3.1MB, pdf)

Articles from Cell Discovery are provided here courtesy of Nature Publishing Group

RESOURCES